Establishment Labs Holdings (ESTA) Interest & Investment Income (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Interest & Investment Income came in at $26000.0 in Q1 2026, down 89.6% year-on-year from $250000.0 in Q1 2025, and down 23.53% quarter-over-quarter from $34000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Interest & Investment Income (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 89.6% year-over-year to $26000.0 in Q1 2026; TTM through Mar 2026 was $199000.0, a 83.94% decrease from a year earlier, with the FY2025 full-year figure at $423000.0, down 71.36% from the prior year.
- Interest & Investment Income slipped to $26000.0 in Q1 2026 per ESTA's latest filing, from $34000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $556000.0 in Q2 2024 and bottomed at $10000.0 in Q3 2022.
- The 5-year median for Interest & Investment Income is $91000.0 (2025), against an average of $178411.8.
- Across the five-year window, Interest & Investment Income surged 2610.0% in 2023 and sank 89.6% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $25000.0 in 2022, then surged by 1916.0% to $504000.0 in 2023, then sank by 60.52% to $199000.0 in 2024, then slumped by 82.91% to $34000.0 in 2025, then slipped by 23.53% to $26000.0 in 2026.
- Per Business Quant, the three latest ESTA Interest & Investment Income figures stand at $26000.0 (Q1 2026), $34000.0 (Q4 2025), and $48000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | 199,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 556,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 504,000.00 |
| Sep 30, 2023 | 271,000.00 |
| Jun 30, 2023 | 170,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 4,000.00 |